TheEdgeResearch
Home / Stocks / MNNDF

Nurosene Health Inc. (MNNDF)

OTC Healthcare Medical - Healthcare Information Services
$0.33 ▼ -8.71%
Market Cap
$14.3M
Sector
Healthcare
Industry
Medical - Healthcare Information Services
Beta
0.00
52-Wk Range
0.1045-0.4904
CEO
George Achilleos
Country
CA
Currency
USD

Nurosene Health Inc. operates in the Medical - Healthcare Information Services industry of the Healthcare sector, headquartered in Toronto, ON, CA. The stock last traded at $0.33, down 8.71% on the session, giving a market capitalisation of $14.3M. On trailing twelve-month figures it carries a trailing P/E of -0.82, a net margin of -11897.3%. Its beta of 0.00 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-0.82
Price / Sales
0.00
Price / Book
1.35
EV / EBITDA
0.00
Gross margin
100.0%
Operating margin
-12116.9%
Net margin
-11897.3%
Return on equity
Debt / equity
0.00
Current ratio
0.25
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
IPO date
2021-09-20
Headquarters
Toronto, ON, CA
About Nurosene Health Inc.

Nurosene Health Inc. is a technology-driven Canadian wellness firm primarily engaged in crafting its own line of specialized health supplements. Among its offerings are Nuro Drive, designed to enhance both physical and cognitive vitality, and Nuro Restore, which aims to improve sleep quality while alleviating stress, discomfort, and inflammation. Furthermore, the company is innovating a mobile virtual care application intended to offer ongoing assistance to individuals dealing with mental health challenges. Nurosene was established in 2019 and is headquartered in Toronto, Canada.

Comparable companies

Nurosene Health Inc. is most often compared with the following Healthcare names:

ABDXFCDXFFNEGXFNOXOFPKANFRAMMFRDTCFRXMDTHKKFTMDIF
More research on MNNDF
MNNDF technical analysis MNNDF TheEdge Score Compare against peers
Open full interactive analysis & DCF →